New eye drug regimen could mean fewer shots for PCV patients
Disease control
Recruiting now
This study tests a higher dose of the drug aflibercept (8 mg) given on a personalized schedule to people with a specific eye condition called polypoidal choroidal vasculopathy (PCV), a type of wet macular degeneration. The goal is to see if this approach can safely extend the tim…
Phase: PHASE3 • Sponsor: Yeungnam University College of Medicine • Aim: Disease control
Last updated May 15, 2026 11:54 UTC